Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Unlock the latest advancements in obesity treatment. Expert insights reveal groundbreaking medical breakthroughs and ...

“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

Here are five questions answered about the FDA's decision to halt compounded versions of GLP-1 drugs. The FDA says state-licensed compounding pharmacies must immediately stop making most compound ...